Medicine for treating rheumatism and rheumatoid diseases

Abstract

The invention provides a medicine for treating rheumatism and rheumatoid diseases. The medicine is prepared from the following Chinese herbal medicines in part by weight: 9 parts of lucid ganoderma, 7 parts of papaya, 7 parts of notoginseng root, 7 parts of safflower, 12 parts of eucommia bark, 18 parts of common clubmoss herb, 8 parts of Chinese angelica, 11 parts of medicinal cyathula root, 6 parts of liquoric root, 3.5 parts of prepared kusnezoff monkshood root, 4.5 parts of prepared common monkshood mother root, 4.2 parts of scorpion, 12.5 parts of gambir plant, 8 parts of himalayan teasel root, 6 parts of cassia twig, 9 parts of dendrobium, 7.5 parts of ephedra herb, 14 parts of siberian solomonseal rhizome, 7 parts of malaytea scurfpea fruit, 7 parts of east asian tree fern rhizome, 4 parts of little multibanded krait, 6 parts of garter snake, 6 parts of Chinese honeylocust spine, 6 parts of stiff silkworm, 5 parts of frankincense, 5 parts of myrrh, 0.5 part of prepared nux vomica, 8 parts of divaricate saposhnikovia root, 8 parts of tuckahoe and 25 parts of medlar. The medicine has the effects of expelling wind-damp, relieving pain or numbness, nourishing blood, promoting blood circulation, dredging collaterals and nourishing yin, and is suitable for treating symptoms of deadlimb, arthralgia and myalgia, waist-leg weakness, arthrocele, dysarthrosis, sluggish flexion and extension of joints and the like which are caused by anemofrigid-damp arthralgia and rheumatic pyretic arthralgia retention.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a medicine for treating rheumatism and rheumatoid diseases, and belongs to the field of traditional Chinese medicines. Background technique [0002] Rheumatism is a clinically common and frequently-occurring disease with a long onset cycle, diverse clinical symptoms, stubborn disease, and long treatment period. Because the etiology and pathogenesis of this type of disease are relatively complicated, the clinical manifestations are mostly borderline and multidisciplinary. In addition to the limitations of traditional Chinese medicine and the inconsistency of understanding of such diseases, it has brought certain difficulties to clinical dialectical treatment and clinical research on such diseases. [0003] In Chinese medicine, rheumatism is collectively referred to as "arthritis". "Huangdi Neijing Suwen" on the forty-third chapter of numbness: "wind, cold, and dampnes...

AI Technical Summary

Problems solved by technology

[0004] In order to solve this difficult problem, people are constantly exploring and researching. However, the therapeutic effect of existing traditional Chinese medicine preparations is still unsatisfactory.